# Optimization of Ionic Matrix Deposition to Increase the Performance of MALDI‐Based Spatial N‐Glycomics

**Authors:** Heidi Vandyk, Christopher Anderton, Hak Joo Lee, Kumar Sharma, Dušan Veličković

PMC · DOI: 10.1002/jms.70053 · Journal of Mass Spectrometry · 2026-03-22

## TL;DR

Researchers improved MALDI matrix conditions to better detect and locate N-glycans in tissues using ionic matrices.

## Contribution

A refined ionic matrix composition (CHCA/DMA·HCl) was developed for enhanced spatial N-glycomics performance.

## Key findings

- Replacing DHB with CHCA and DMA with DMA·HCl improved sensitivity for N-glycan detection in tissues.
- The new matrix preserved endogenous glycan localization while detecting low-abundance sialic acid glycans.
- The method outperformed traditional CHCA matrices used in spatial N-glycomics.

## Abstract

Ionic matrices for matrix‐assisted laser desorption/ionization (MALDI) have demonstrated superior performance compared to traditional matrices for profiling and screening of carbohydrate composition. However, their application in MALDI‐MS imaging of N‐glycans in tissues remains elusive, in part due to suboptimal matrix application conditions. In this study, we optimized 2,5‐dihydroxybenzoic acid/N, N‐dimethylaniline (DHB/DMA) ionic matrix spray conditions to enhance the sensitivity of spotted N‐glycan standards; however, these conditions were not suitable for analyzing endogenous N‐glycans in tissue. To address this, we refined the composition of the ionic matrix by replacing DHB with α‐cyano‐4‐hydroxycinnamic acid (CHCA) and DMA with its hydrochloride salt (DMA·HCl), resulting in superior performance compared to the CHCA matrix, which is the most widely used for spatial N‐glycomics. This method enhanced the sensitivity for detecting diverse N‐glycan types, including low‐abundance sialic acid glycans, while maintaining their endogenous location—a key limitation of liquid‐state DMA.

## Linked entities

- **Chemicals:** 2,5-dihydroxybenzoic acid (PubChem CID 3469), N,N-dimethylaniline (PubChem CID 949), α-cyano-4-hydroxycinnamic acid (PubChem CID 2102), DMA·HCl (PubChem CID 523006), sialic acid (PubChem CID 445063)

## Full-text entities

- **Diseases:** type 2 diabetes (MESH:D003924)
- **Chemicals:** glycan (MESH:D011134), 2,5-dihydroxybenzoic acid (MESH:C010925), sialic acid (MESH:D019158), NaCl (MESH:D012965), N (MESH:D009584), hemicellulose (MESH:C007916), sugars (MESH:D000073893), CHCA (MESH:C007175), ITO (MESH:C109984), water (MESH:D014867), carbohydrate (MESH:D002241), KNO3 (MESH:C023844), oligosaccharide (MESH:D009844), N, N-dimethylaniline (MESH:C015157), sialic acids (MESH:D012794), Nd (MESH:D009354), salt (MESH:D012492), benzene (MESH:D001554), sulfates (MESH:D013431), DHB (MESH:C003870), Man 5 (-), paraffin (MESH:D010232), DMA (MESH:C405765), acetonitrile (MESH:C032159), formalin (MESH:D005557), TFA (MESH:D014269)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006149/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13006149/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006149/full.md

---
Source: https://tomesphere.com/paper/PMC13006149